Title of article - Reforming the Veterans Health Administration--Beyond Palliation of Symptoms.
Abstract
BRAF V600E is the genetic lesion underlying hairy-cell leukemia. We assessed the safety and activity of the oral BRAF inhibitor vemurafenib in patients with hairy-cell leukemia that had relapsed after treatment with a purine analogue or who had disease that was refractory to purine analogues.
CLICK HERE for Full article Click button above to go to original article link with complete article details for Reforming the Veterans Health Administration--Beyond Palliation of Symptoms.
Please CLICK HERE to discuss with us on facebook about this article.
Click below for Details of research Institute
From the Health Policy Institute, Texas Medical Center, Houston (B.P.G.); and Project HOPE, Bethesda, MD (G.R.W.). Drs. Giroir and Wilensky cochaired the blue-ribbon panel on the Veterans Health Administration; the other members of the panel were Katrina Armstrong, Debra Barksdale, Ronald R. Blanck, W. Warner Burke, Christine K. Cassel, Peter W. Chiarelli, George Halvorson, Robert L. Mallett, Robert Margolis, George Poste, Robert Robbins, Mark D. Smith, Glenn D. Steele, and Beth Ann Swan.
Details of Journal for Reforming the Veterans Health Administration--Beyond Palliation of Symptoms.
Journal Title - The New England journal of medicine
ISSN - 1533-4406
Volume - 373
Issue - 18
Publish date - 2015-Oct
Language - eng
Country - United States
No comments:
Post a Comment